tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Sanofi (SNY)
NASDAQ:SNY
US Market
SNY
Sanofi
Overview
Analyst Forecasts
AI Stock Analysis
Popular
Dividends
Earnings
Ownership
Financials
Statistics
New
Technical Analysis
Historical Prices
New
News & Insights
Chart
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports
Advertisement

Sanofi (SNY) Stock News & Sentiment

Compare
2,065 Followers
Sanofi’s Wayrilz Gains FDA Approval as First BTK Inhibitor for ITP
Premium
Company Announcements
Sanofi’s Wayrilz Gains FDA Approval as First BTK Inhibitor for ITP
21h ago
6K
SNY
Sanofi’s Rilzabrutinib Gains EU Orphan Designation for IgG4-Related Disease
Premium
Company Announcements
Sanofi’s Rilzabrutinib Gains EU Orphan Designation for IgG4-Related Disease
6d ago
6K
SNY
Regeneron and Sanofi’s Dupilumab Study: A Potential Game-Changer for Prurigo Nodularis Treatment
Premium
Company Announcements
Regeneron and Sanofi’s Dupilumab Study: A Potential Game-Changer for Prurigo Nodularis Treatment
13d ago
SNY
REGN
Sanofi’s New Vaccine Trial: A Potential Game-Changer for Infant Health
Premium
Company Announcements
Sanofi’s New Vaccine Trial: A Potential Game-Changer for Infant Health
13d ago
SNY
Sanofi’s Dupilumab Study: A Potential Game-Changer for Chronic Pruritus Treatment
Premium
Company Announcements
Sanofi’s Dupilumab Study: A Potential Game-Changer for Chronic Pruritus Treatment
13d ago
SNY
Sanofi’s Promising Phase 2a Diabetes Study: A Potential Game-Changer?
Premium
Company Announcements
Sanofi’s Promising Phase 2a Diabetes Study: A Potential Game-Changer?
13d ago
SNY
Sanofi’s Phase 3 Study on PCV21 Vaccine: A Potential Game-Changer in Pediatric Health
Premium
Company Announcements
Sanofi’s Phase 3 Study on PCV21 Vaccine: A Potential Game-Changer in Pediatric Health
13d ago
SNY
More SNY News >

SNY News on the Web

Sanofi's Amlitelimab Meets Primary & Key Secondary Endpoints In Phase 3 Study For Atopic Dermatitis
rttnews
Neutral
MRK Posts Cholesterol Drug Data, Focus Shifts Back to Its Pipeline
Zacks
Neutral
Sanofi Gets FDA Nod for Wayrilz in Immune Thrombocytopenia
Zacks
Neutral
Sanofi’s Rilzabrutinib Gains EU Orphan Designation for IgG4-Related Disease
TipRanks News
Neutral
Will Weak Gardasil Sales Continue to Be a Drag on MRK's Top Line?
Zacks
Neutral
Biotech Stocks Facing FDA Decision In September 2025
rttnews
Neutral
Can Eylea HD and Dupixent Profits Revive Regeneron Stock?
Zacks
Neutral
SNY's Rilzabrutinib Gets EU Orphan Drug Tag for IgG4-Related Disease
Zacks
Neutral

News Score - Last 7 Days

Neutral
SNY
Sector Average
Media Buzz
This Week3 articles
Weekly Average1.75 articles
News Sentiment
This Week50%
Sector Average56%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is SNY’s Media Buzz Sentiment?
3 articles about SNY were published this week. In an average week, 1.75 articles are published.
    What is SNY’s weekly average amount of articles?
    In an average week, 1.75 articles about SNY are published.
      What is SNY’s News Sentiment?
      50% of articles about SNY were positive this week, compared to its sector average of 56%.
        Healthcare Stocks that are Trending in the News
        HALOHalozyme
        UTHRUnited Therapeutics
        KNSAKiniksa Pharmaceuticals
        AXSMAxsome Therapeutics
        PNTGPennant Group
        Showing the stocks with the most bullish news sentiment over the past week

        Become an Expert with TipRanks Premium

        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis
        Subscribe NowSee Plans & Pricing